CIK: 0001855655 · Show all filings
Period: Q3 2025 (← Previous) (Next →)
Filing Date: Nov 14, 2025
Total Value ($000): $3,516,197 (100.0% shares, 0.0% debt)
| Ticker | Issuer | Shares | Value ($000) | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| NUVL | NUVALENT INC | 5,269,433 | $455,701 | 13.0% | $60.72 | +30.2% | COM | 670703107 |
| — | MERUS N V | 4,373,770 | $411,790 | 11.7% | $51.34 | — | COM | N5749R100 |
| ACLX | ARCELLX INC | 4,649,016 | $381,684 | 10.9% | $41.59 | +73.1% | COMMON STOCK | 03940C100 |
| RVMD | REVOLUTION MEDICINES INC | 6,223,291 | $290,628 | 8.3% | $36.52 | +7.2% | COM | 76155X100 |
| TARS | TARSUS PHARMACEUTICALS INC | 2,665,698 | $158,422 | 4.5% | $28.61 | +72.1% | COM | 87650L103 |
| PCVX | VAXCYTE INC | 3,784,755 | $136,327 | 3.9% | $56.25 | -41.1% | COM | 92243G108 |
| ABVX | ABIVAX SA | 1,564,196 | $132,800 | 3.8% | $84.90 | — | SPONSORED ADS | 00370M103 |
| GMAB | GENMAB A/S | 3,816,851 | $117,063 | 3.3% | $30.67 | — | SPONSORED ADS | 372303206 |
| AGIO | AGIOS PHARMACEUTICALS INC | 2,673,555 | $107,316 | 3.1% | $34.49 | +9.0% | COM | 00847X104 |
| CRNX | CRINETICS PHARMACEUTICALS IN | 2,550,774 | $106,240 | 3.0% | $26.84 | +19.1% | COM | 22663K107 |
| XBI | SPDR SERIES TRUST | 1,000,000 | $100,200 | 2.8% | — | — | Put | 78464A870 |
| EWTX | EDGEWISE THERAPEUTICS INC | 6,170,131 | $100,080 | 2.8% | $20.10 | -29.4% | COM | 28036F105 |
| — | CIDARA THERAPEUTICS INC | 961,164 | $92,041 | 2.6% | $95.76 | — | COM NEW | 171757206 |
| URGN | UROGEN PHARMA LTD | 4,216,084 | $84,111 | 2.4% | $17.96 | 0.0% | COM | M96088105 |
| SRRK | SCHOLAR ROCK HLDG CORP | 2,009,745 | $74,843 | 2.1% | $32.12 | +8.9% | COM | 80706P103 |
| JANX | JANUX THERAPEUTICS INC | 2,920,258 | $71,371 | 2.0% | $48.02 | -49.3% | COM | 47103J105 |
| OLMA | OLEMA PHARMACEUTICALS INC | 6,794,172 | $66,515 | 1.9% | $8.25 | -27.2% | COM | 68062P106 |
| APGE | APOGEE THERAPEUTICS INC | 1,521,757 | $60,459 | 1.7% | $44.51 | -14.2% | COM | 03770N101 |
| VRDN | VIRIDIAN THERAPEUTICS INC | 2,609,353 | $56,310 | 1.6% | $17.86 | +1.0% | COM | 92790C104 |
| ALKS | ALKERMES PLC | 1,719,334 | $51,580 | 1.5% | $29.45 | -4.2% | SHS | G01767105 |
| LENZ | LENZ THERAPEUTICS INC | 1,073,461 | $50,002 | 1.4% | $27.56 | +33.4% | COM | 52635N103 |
| PHVS | PHARVARIS N V | 1,835,494 | $45,796 | 1.3% | $18.67 | +18.8% | COM | N69605108 |
| COGT | COGENT BIOSCIENCES INC | 3,156,398 | $45,326 | 1.3% | $7.69 | +54.1% | COM | 19240Q201 |
| OCUL | OCULAR THERAPEUTIX INC | 3,497,307 | $40,884 | 1.2% | $7.86 | +52.0% | COM | 67576A100 |
| BBIO | BRIDGEBIO PHARMA INC | 684,277 | $35,541 | 1.0% | $36.37 | +34.1% | COM | 10806X102 |
| ERAS | ERASCA INC | 13,560,017 | $29,561 | 0.8% | $2.19 | -27.4% | COM | 29479A108 |
| EYPT | EYEPOINT PHARMACEUTICALS INC | 2,005,365 | $28,556 | 0.8% | $11.51 | 0.0% | COM NEW | 30233G209 |
| — | MERUS N V | 300,000 | $28,245 | 0.8% | $51.34 | — | Call | N5749R100 |
| TNGX | TANGO THERAPEUTICS INC | 3,086,184 | $25,924 | 0.7% | $6.77 | 0.0% | COM | 87583X109 |
| AMLX | AMYLYX PHARMACEUTICALS INC | 1,900,000 | $25,821 | 0.7% | $9.41 | 0.0% | COM | 03237H101 |
| SYRE | SPYRE THERAPEUTICS INC | 1,467,266 | $24,591 | 0.7% | $26.04 | -37.4% | COM NEW | 00773J202 |
| DYN | DYNE THERAPEUTICS INC | 1,898,950 | $24,022 | 0.7% | $11.41 | 0.0% | COM | 26818M108 |
| BBOT | BRIDGEBIO ONCOLOGY THERAPEUT | 1,866,141 | $21,610 | 0.6% | $11.58 | — | COM NEW | 107924102 |
| IRON | DISC MEDICINE INC | 247,716 | $16,369 | 0.5% | $48.64 | +22.3% | COM | 254604101 |
| GPCR | STRUCTURE THERAPEUTICS INC | 372,869 | $10,440 | 0.3% | $28.00 | — | SPONSORED ADS | 86366E106 |
| AGIO | AGIOS PHARMACEUTICALS INC | 200,000 | $8,028 | 0.2% | $34.49 | +9.0% | Call | 00847X104 |